RXRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 19.96%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $13,435,990.94

Recursion Pharmaceuticals Insider Trading History Chart

Recursion Pharmaceuticals Share Price & Price History

^$7.57

▼ -0.22 (-2.82%)

As of 04/16/2024 05:00 PM ET

Days: 30 | 90 | 365

AI “wealth window” is closing soon!

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

Recursion Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/3/2024	Christopher Gibson	CEO	Sell	40,000	$8.84	$353,600.00	978,524
4/2/2024	Blake Borgeson	Director	Sell	11,447	$8.82	$100,962.54	7,241,308
3/28/2024	Christopher Gibson	CEO	Sell	40,000	$10.10	$404,000.00	1,043,524
3/21/2024	Tina Marriott	COO	Sell	8,000	$10.75	$86,000.00	639,982
3/19/2024	Blake Borgeson	Director	Sell	20,054	$10.79	$216,382.66	7,252,755
3/13/2024	Michael Secora	CFO	Sell	25,000	$11.03	$275,750.00	1,204,179
3/6/2024	Christopher Gibson	CEO	Sell	36,319	$11.86	$430,743.34	1,108,524
3/5/2024	Blake Borgeson	Director	Sell	20,054	$12.06	$241,851.24	7,272,809
2/22/2024	Tina Marriott	COO	Sell	8,000	$14.89	$119,120.00	639,982
2/20/2024	Blake Borgeson	Director	Sell	20,054	$12.32	$247,065.28	7,292,863
2/13/2024	Michael Secora	CFO	Sell	25,000	$9.86	$246,500.00	1,173,851
2/7/2024	Christopher Gibson	CEO	Sell	48,272	$9.22	$445,067.84	774,703
2/6/2024	Blake Borgeson	Director	Sell	11,447	$9.30	$106,457.10	7,312,917
1/25/2024	Tina Marriott Larson	COO	Sell	8,000	$10.35	$82,800.00	414,548
1/23/2024	Blake Borgeson	Director	Sell	20,054	$10.58	$212,171.32	7,324,364
1/16/2024	Michael Secora	CFO	Sell	25,000	$10.45	$261,250.00	968,514
1/16/2024	Shafique Virani	Insider	Sell	18,000	$10.93	$196,740.00	136,748
1/9/2024	Dean Y. Li	Director	Sell	29,000	$13.66	$396,140.00	421,000
1/3/2024	Christopher Gibson	CEO	Sell	30,853	$9.49	$292,794.97	791,725
12/26/2023	Blake Borgeson	Director	Sell	20,054	$10.63	$213,174.02	7,364,472
12/15/2023	Shafique Virani	Insider	Sell	18,000	$9.60	$172,800.00	136,748
12/14/2023	Zavain Dar	Director	Sell	20,141	$9.00	$181,269.00	53,823
12/12/2023	Blake Borgeson	Director	Sell	11,447	$7.40	$84,707.80	7,384,526
12/12/2023	Michael Secora	CFO	Sell	25,000	$7.39	$184,750.00	943,514
12/6/2023	Christopher Gibson	CEO	Sell	59,829	$7.49	$448,119.21	791,328
11/28/2023	Blake Borgeson	Director	Sell	11,447	$6.72	$76,923.84	7,395,973
11/16/2023	Tina Marriott Larson	COO	Sell	3,000	$6.76	$20,280.00	413,404
11/15/2023	Shafique Virani	Insider	Sell	18,000	$6.51	$117,180.00	140,351
11/14/2023	Blake Borgeson	Director	Sell	8,885	$6.32	$56,153.20	7,407,420
11/14/2023	Michael Secora	CFO	Sell	25,000	$6.32	$158,000.00	925,686
11/1/2023	Christopher Gibson	CEO	Sell	37,177	$5.20	$193,320.40	836,820
10/31/2023	Blake Borgeson	Director	Sell	8,885	$5.27	$46,823.95	7,416,305
10/26/2023	Tina Marriott Larson	COO	Sell	3,000	$5.63	$16,890.00	418,782
10/17/2023	Blake Borgeson	Director	Sell	8,885	$6.58	$58,463.30	7,425,190
10/16/2023	Shafique Virani	Insider	Sell	18,000	$6.30	$113,400.00	140,351
10/10/2023	Michael Secora	CFO	Sell	25,000	$7.07	$176,750.00	900,686
10/4/2023	Christopher Gibson	CEO	Sell	59,794	$7.21	$431,114.74	842,747
10/3/2023	Blake Borgeson	Director	Sell	8,885	$7.29	$64,771.65	7,434,075
9/28/2023	Tina Marriott Larson	COO	Sell	3,000	$7.72	$23,160.00	418,782
9/19/2023	Blake Borgeson	Director	Sell	8,885	$8.36	$74,278.60	7,442,960
9/15/2023	Shafique Virani	Insider	Sell	18,000	$8.66	$155,880.00	140,351
9/13/2023	Michael Secora	CFO	Sell	25,000	$8.69	$217,250.00	888,186
9/6/2023	Christopher Gibson	CEO	Sell	33,765	$8.78	$296,456.70	871,291
9/5/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,451,845
8/24/2023	Tina Marriott Larson	COO	Sell	3,000	$8.66	$25,980.00	418,782
8/22/2023	Blake Borgeson	Director	Sell	8,885	$8.91	$79,165.35	7,460,730
8/16/2023	Michael Secora	CFO	Sell	25,000	$8.90	$222,500.00	863,186
8/15/2023	Shafique Virani	Insider	Sell	18,000	$9.25	$166,500.00	140,351
8/8/2023	Blake Borgeson	Director	Sell	17,770	$11.16	$198,313.20	7,469,615
8/2/2023	Christopher Gibson	CEO	Sell	65,015	$13.04	$847,795.60	890,719
7/27/2023	Tina Marriott Larson	COO	Sell	8,000	$13.62	$108,960.00	424,160
7/26/2023	Shafique Virani	Insider	Sell	20,000	$14.41	$288,200.00	143,954
7/25/2023	Blake Borgeson	Director	Sell	18,719	$14.61	$273,484.59	7,487,385
7/18/2023	Michael Secora	CFO	Sell	25,000	$13.63	$340,750.00	830,413
7/17/2023	Shafique Virani	Insider	Sell	30,000	$11.72	$351,600.00	143,954
7/13/2023	Terry-Ann Burrell	Director	Sell	8,275	$12.59	$104,182.25	54,847
7/12/2023	Christopher Gibson	CEO	Sell	31,818	$13.14	$418,088.52	915,810
7/11/2023	Blake Borgeson	Director	Sell	8,885	$6.89	$61,217.65	7,520,104
6/29/2023	Tina Marriott Larson	COO	Sell	3,000	$7.49	$22,470.00	424,160
6/27/2023	Blake Borgeson	Director	Sell	8,885	$7.39	$65,660.15	7,528,989
6/13/2023	Blake Borgeson	Director	Sell	15,485	$9.98	$154,540.30	7,525,262
6/13/2023	Michael Secora	CFO	Sell	25,000	$9.93	$248,250.00	805,413
6/7/2023	Christopher Gibson	CEO	Sell	56,436	$9.05	$510,745.80	916,378
6/1/2023	Shafique Virani	Insider	Sell	25,000	$8.58	$214,500.00	161,819
5/31/2023	Tina Marriott Larson	COO	Sell	3,000	$8.63	$25,890.00	424,160
5/30/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,540,747
5/16/2023	Blake Borgeson	Director	Sell	8,885	$5.09	$45,224.65	7,549,632
5/3/2023	Christopher Gibson	CEO	Sell	33,073	$4.71	$155,773.83	953,225
4/18/2023	Blake Borgeson	Director	Sell	8,885	$5.93	$52,688.05	7,558,517
4/5/2023	Christopher Gibson	CEO	Sell	13,327	$6.46	$86,092.42	946,710
4/4/2023	Blake Borgeson	Director	Sell	8,885	$6.53	$58,019.05	7,567,402
3/21/2023	Blake Borgeson	Director	Sell	8,885	$7.40	$65,749.00	7,576,287
3/8/2023	Christopher Gibson	CEO	Sell	70,890	$8.10	$574,209.00	963,787
3/7/2023	Blake Borgeson	Director	Sell	8,885	$8.33	$74,012.05	7,585,172
3/2/2023	Christopher Gibson	CEO	Sell	18,500	$7.92	$146,520.00	940,927
2/27/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	52,500	$7.69	$403,725.00	12,869,423
2/23/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	51,864	$7.79	$404,020.56	12,707,805
2/23/2023	Tina Marriott Larson	COO	Sell	8,000	$7.82	$62,560.00	427,844
2/21/2023	Blake Borgeson	Director	Sell	8,885	$7.73	$68,681.05	7,594,057
2/21/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	94,418	$7.74	$730,795.32	12,605,000
2/16/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	42,682	$7.90	$337,187.80	12,447,200
2/15/2023	Shafique Virani	Insider	Sell	7,486	$8.33	$62,358.38	189,846
2/14/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	6,300	$7.95	$50,085.00	12,404,518
2/10/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	11,000	$7.98	$87,780.00	12,365,744
2/7/2023	Blake Borgeson	Director	Sell	8,885	$8.81	$78,276.85	7,602,942
1/26/2023	Tina Marriott Larson	COO	Sell	8,000	$8.07	$64,560.00	203,654
1/25/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	24,526	$7.88	$193,264.88	12,346,258
1/24/2023	Blake Borgeson	Director	Sell	8,885	$8.71	$77,388.35	7,611,827
1/17/2023	Shafique Virani	Insider	Sell	10,000	$9.16	$91,600.00	73,160
1/10/2023	Blake Borgeson	Director	Sell	8,885	$7.69	$68,325.65	7,620,712
1/9/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	76,046	$7.64	$580,991.44	12,252,214
1/5/2023	Christopher Gibson	CEO	Sell	18,500	$7.39	$136,715.00	525,805
1/5/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	80,035	$7.38	$590,658.30	12,107,215
1/3/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	141,646	$7.50	$1,062,345.00	11,935,288
12/29/2022	Tina Marriott Larson	COO	Sell	8,000	$7.70	$61,600.00	203,654
12/27/2022	Blake Borgeson	Director	Sell	8,885	$7.25	$64,416.25	7,628,272
12/15/2022	Shafique Virani	Insider	Sell	10,000	$8.85	$88,500.00	78,160
12/13/2022	Blake Borgeson	Director	Sell	8,885	$8.96	$79,609.60	7,637,157
12/1/2022	Christopher Gibson	CEO	Sell	37,210	$9.02	$335,634.20	582,805
11/29/2022	Blake Borgeson	Director	Sell	8,885	$8.75	$77,743.75	7,646,042
11/17/2022	Tina Marriott Larson	COO	Sell	16,000	$10.96	$175,360.00	203,654
11/16/2022	Blake Borgeson	Director	Sell	17,770	$11.12	$197,602.40	7,654,927
11/15/2022	Shafique Virani	Insider	Sell	10,000	$12.31	$123,100.00	83,160
11/3/2022	Christopher Gibson	CEO	Sell	36,693	$10.00	$366,930.00	576,016
10/27/2022	Tina Marriott Larson	COO	Sell	16,000	$10.72	$171,520.00	205,107
10/14/2022	Shafique Virani	Insider	Sell	10,000	$10.92	$109,200.00	88,773
10/6/2022	Christopher Gibson	CEO	Sell	36,053	$11.58	$417,493.74	562,959
9/29/2022	Tina Marriott Larson	COO	Sell	16,000	$10.86	$173,760.00	205,107
9/15/2022	Shafique Virani	Insider	Sell	10,000	$13.36	$133,600.00	93,773
8/16/2022	Shafique Virani	Insider	Sell	30,000	$12.61	$378,300.00	98,773
8/16/2022	Tina Marriott Larson	COO	Sell	16,000	$12.60	$201,600.00	295,107
8/4/2022	Christopher Gibson	CEO	Sell	36,825	$9.49	$349,469.25	541,829
7/7/2022	Christopher Gibson	CEO	Sell	37,114	$9.05	$335,881.70	528,904
6/2/2022	Christopher Gibson	CEO	Sell	39,690	$6.09	$241,712.10	516,268
5/4/2022	Christopher Gibson	CEO	Sell	31,830	$6.49	$206,576.70	511,972
4/28/2022	Christopher Gibson	CEO	Sell	37,605	$6.09	$229,014.45	469,608
4/21/2022	Christopher Gibson	CEO	Sell	37,155	$6.31	$234,448.05	420,146
4/18/2022	Christopher Gibson	CEO	Sell	35,836	$6.84	$245,118.24	394,791
4/14/2022	Christopher Gibson	CEO	Sell	34,517	$7.56	$260,948.52	368,117
4/7/2022	Christopher Gibson	CEO	Sell	36,718	$6.54	$240,135.72	314,534
4/5/2022	Christopher Gibson	CEO	Sell	34,472	$7.43	$256,126.96	288,742
3/14/2022	Christopher Gibson	CEO	Sell	230,000	$6.28	$1,444,400.00
3/11/2022	Christopher Gibson	CEO	Sell	100,000	$6.95	$695,000.00
3/7/2022	Christopher Gibson	CEO	Sell	300,000	$7.30	$2,190,000.00
2/22/2022	Christopher Gibson	CEO	Sell	100,000	$10.22	$1,022,000.00
1/31/2022	Christopher Gibson	CEO	Sell	19,858	$11.73	$232,934.34
1/13/2022	Christopher Gibson	CEO	Sell	87,000	$14.33	$1,246,710.00
1/4/2022	Blake Borgeson	Director	Sell	9,625	$18.03	$173,538.75
12/21/2021	Blake Borgeson	Director	Sell	9,625	$18.75	$180,468.75
12/16/2021	Christopher Gibson	CEO	Sell	200	$20.00	$4,000.00
12/16/2021	Tina Marriott Larson	COO	Sell	2,500	$18.74	$46,850.00
12/13/2021	Christopher Gibson	CEO	Sell	100	$20.02	$2,002.00
12/9/2021	Christopher Gibson	CEO	Sell	1,086	$20.01	$21,730.86
12/7/2021	Blake Borgeson	Director	Sell	9,625	$20.32	$195,580.00
12/7/2021	Christopher Gibson	CEO	Sell	3,125	$20.51	$64,093.75
11/19/2021	Dean Y. Li	Director	Sell	13,474	$20.20	$272,174.80
11/18/2021	Tina Marriott Larson	COO	Sell	2,500	$18.92	$47,300.00
11/17/2021	Dean Y. Li	Director	Sell	5,626	$20.04	$112,745.04

AI “wealth window” is closing soon!

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

SEC Filings (Institutional Ownership Changes) for Recursion Pharmaceuticals (NASDAQ:RXRX)

89.06% of Recursion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Recursion Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/15/2024	TB Alternative Assets Ltd.	70,800	$0.71M	0.2%	N/A	0.030%
4/10/2024	Wedmont Private Capital	18,943	$0.17M	0.0%	+11.8%	0.008%
4/10/2024	Green Alpha Advisors LLC	72,434	$0.72M	0.5%	+6.7%	0.031%
3/11/2024	Vanguard Group Inc.	15,665,210	$154.46M	0.0%	+1.0%	6.676%
3/5/2024	Mubadala Investment Co PJSC	12,985,927	$128.04M	0.4%	N/A	5.995%
3/1/2024	Goldman Sachs Group Inc.	1,191,805	$11.75M	0.0%	+79.3%	0.550%
2/26/2024	Teachers Retirement System of The State of Kentucky	171,327	$1.69M	0.0%	-1.1%	0.079%
2/16/2024	Price T Rowe Associates Inc. MD	56,564	$0.56M	0.0%	+6.8%	0.026%
2/16/2024	GSA Capital Partners LLP	10,860	$0.11M	0.0%	N/A	0.005%
2/15/2024	Employees Retirement System of Texas	22,398	$0.22M	0.0%	N/A	0.010%
2/15/2024	Legal & General Group Plc	129,621	$1.28M	0.0%	+9.8%	0.060%
2/15/2024	Barclays PLC	596,558	$5.88M	0.0%	+7.0%	0.275%
2/15/2024	Vanguard Group Inc.	15,665,210	$154.46M	0.0%	+1.0%	7.232%
2/15/2024	Voloridge Investment Management LLC	584,955	$5.77M	0.0%	-31.5%	0.270%
2/15/2024	Vident Advisory LLC	19,768	$0.20M	0.0%	-27.2%	0.009%
2/15/2024	Nvidia Corp	7,706,363	$75.99M	33.0%	N/A	3.557%
2/15/2024	Nuveen Asset Management LLC	556,903	$5.49M	0.0%	-43.6%	0.257%
2/15/2024	Prelude Capital Management LLC	19,733	$0.20M	0.0%	-54.1%	0.009%
2/15/2024	Price T Rowe Associates Inc. MD	56,564	$0.56M	0.0%	+6.8%	0.026%
2/15/2024	Profund Advisors LLC	162,625	$1.60M	0.1%	-11.7%	0.075%
2/15/2024	Comerica Bank	2,838	$28K	0.0%	+966.9%	0.001%
2/14/2024	Royal Bank of Canada	34,065	$0.34M	0.0%	+30.2%	0.016%
2/14/2024	Pathstone Holdings LLC	46,027	$0.45M	0.0%	N/A	0.021%
2/14/2024	Point72 Asset Management L.P.	1,470,200	$14.50M	0.0%	+969.2%	0.679%
2/14/2024	Cresset Asset Management LLC	52,169	$0.51M	0.0%	+246.0%	0.024%
2/14/2024	Platinum Investment Management Ltd.	2,273,964	$22.42M	0.9%	-2.6%	1.050%
2/13/2024	Envestnet Asset Management Inc.	127,440	$1.26M	0.0%	N/A	0.059%
2/13/2024	Northern Trust Corp	1,295,587	$12.77M	0.0%	-1.0%	0.598%
2/13/2024	Cetera Advisor Networks LLC	36,628	$0.36M	0.0%	N/A	0.017%
2/13/2024	Tower Research Capital LLC TRC	13,604	$0.13M	0.0%	+64.1%	0.006%
2/13/2024	First Trust Advisors LP	252,693	$2.49M	0.0%	+7.8%	0.117%
2/13/2024	Goldman Sachs Group Inc.	1,191,805	$11.75M	0.0%	+79.3%	0.550%
2/13/2024	CIBC Private Wealth Group LLC	136,753	$1.35M	0.0%	N/A	0.063%
2/13/2024	Lingotto Investment Management LLP	1,875,077	$18.49M	0.9%	+141.9%	0.866%
2/13/2024	Rafferty Asset Management LLC	1,090,173	$10.75M	0.0%	-1.3%	0.503%
2/13/2024	The Manufacturers Life Insurance Company	72,171	$0.71M	0.0%	-3.4%	0.033%
2/13/2024	KBC Group NV	4,225	$42K	0.0%	N/A	0.002%
2/13/2024	California State Teachers Retirement System	149,663	$1.48M	0.0%	+3.7%	0.069%
2/12/2024	Elevatus Welath Management	24,650	$0.24M	0.1%	N/A	0.011%
2/12/2024	Stifel Financial Corp	27,189	$0.27M	0.0%	N/A	0.013%
2/9/2024	Nomura Asset Management Co. Ltd.	46,369	$0.46M	0.0%	N/A	0.021%
2/9/2024	Cambridge Investment Research Advisors Inc.	63,996	$0.63M	0.0%	+6.9%	0.030%
2/9/2024	Quest Partners LLC	19,668	$0.19M	0.0%	N/A	0.009%
2/9/2024	Gladstone Institutional Advisory LLC	13,492	$0.13M	0.0%	N/A	0.006%
2/9/2024	UBS Group AG	691,911	$6.82M	0.0%	+101.9%	0.319%
2/9/2024	Norges Bank	3,531,964	$34.83M	0.0%	N/A	1.630%
2/8/2024	Marathon Capital Management	164,880	$1.63M	0.4%	-3.4%	0.076%
2/8/2024	Nikko Asset Management Americas Inc.	9,203,780	$90.57M	0.9%	+161.2%	4.249%
2/8/2024	Foundations Investment Advisors LLC	73,658	$0.70M	0.0%	+233.2%	0.034%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	26,055	$0.25M	0.0%	-21.1%	0.012%
2/7/2024	Ieq Capital LLC	34,048	$0.34M	0.0%	+26.7%	0.016%
2/7/2024	Principal Financial Group Inc.	683,608	$6.74M	0.0%	+5.9%	0.316%
2/7/2024	Dimensional Fund Advisors LP	2,137,110	$21.08M	0.0%	+152.9%	0.987%
2/7/2024	Teacher Retirement System of Texas	32,432	$0.32M	0.0%	-11.5%	0.015%
2/7/2024	E Fund Management Co. Ltd.	54,094	$0.53M	0.0%	-4.6%	0.025%
2/6/2024	Charles Schwab Investment Management Inc.	1,190,882	$11.74M	0.0%	+2.8%	0.550%
2/6/2024	National Bank of Canada FI	3,150	$31K	0.0%	+90.9%	0.001%
2/6/2024	Vestmark Advisory Solutions Inc.	472,256	$4.66M	0.2%	N/A	0.218%
2/6/2024	Axxcess Wealth Management LLC	22,997	$0.23M	0.0%	N/A	0.011%
2/6/2024	Amalgamated Bank	11,944	$0.12M	0.0%	-10.5%	0.006%
2/6/2024	First Horizon Advisors Inc.	4,765	$47K	0.0%	N/A	0.002%
2/6/2024	Swiss National Bank	281,400	$2.78M	0.0%	-1.0%	0.130%
2/5/2024	Victory Capital Management Inc.	20,441	$0.20M	0.0%	+34.1%	0.009%
2/5/2024	Russell Investments Group Ltd.	109,013	$1.08M	0.0%	-16.7%	0.050%
2/1/2024	New York State Common Retirement Fund	58,414	$0.58M	0.0%	+21.1%	0.027%
2/1/2024	Handelsbanken Fonder AB	34,100	$0.34M	0.0%	+52.2%	0.016%
1/31/2024	Daiwa Securities Group Inc.	11,759	$0.12M	0.0%	+1,508.6%	0.005%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	40,658	$0.40M	0.0%	+32.8%	0.019%
1/30/2024	Sumitomo Mitsui Trust Holdings Inc.	9,203,780	$90.75M	0.1%	+161.2%	4.249%
1/26/2024	Cherry Creek Investment Advisors Inc.	17,853	$0.18M	0.1%	N/A	0.008%
1/26/2024	Baillie Gifford & Co.	24,179,504	$238.41M	0.2%	-1.5%	11.162%
1/25/2024	International Assets Investment Management LLC	16,762	$1.70M	0.0%	+1,423.8%	0.008%
1/24/2024	International Assets Investment Management LLC	16,762	$1.70M	0.0%	+1,423.8%	0.008%
1/24/2024	Arizona State Retirement System	39,926	$0.39M	0.0%	+8.5%	0.018%
1/24/2024	China Universal Asset Management Co. Ltd.	24,091	$0.24M	0.0%	+360.0%	0.011%
1/18/2024	Brave Asset Management Inc.	15,000	$0.15M	0.0%	N/A	0.007%
1/18/2024	Values First Advisors Inc.	59,205	$0.58M	0.4%	+11.6%	0.027%
1/17/2024	ARK Investment Management LLC	20,654,287	$203.65M	1.2%	+200.4%	9.535%
1/12/2024	SG Americas Securities LLC	22,186	$0.22M	0.0%	-43.0%	0.010%
1/9/2024	Interchange Capital Partners LLC	22,793	$0.22M	0.2%	N/A	0.011%
1/5/2024	Exchange Traded Concepts LLC	16,359	$0.16M	0.0%	+34.0%	0.008%
1/5/2024	Green Alpha Advisors LLC	67,871	$0.67M	0.5%	+96.5%	0.031%
1/1/2024	Teachers Retirement System of The State of Kentucky	173,309	$1.33M	0.0%	-0.6%	0.080%
12/18/2023	Vanguard Group Inc.	15,506,834	$118.63M	0.0%	+37.7%	7.159%
12/7/2023	Hudson Bay Capital Management LP	40,000	$0.31M	0.0%	-63.6%	0.018%
12/6/2023	Citigroup Inc.	470,512	$3.60M	0.0%	+165.3%	0.217%
11/30/2023	American Century Companies Inc.	85,925	$0.66M	0.0%	+741.3%	0.040%
11/24/2023	Deutsche Bank AG	59,688	$0.46M	0.0%	+15.4%	0.028%
11/16/2023	Creative Planning	18,287	$0.14M	0.0%	N/A	0.008%
11/16/2023	GTS Securities LLC	10,476	$80K	0.0%	N/A	0.005%
11/16/2023	Tudor Investment Corp Et Al	21,544	$0.17M	0.0%	N/A	0.010%
11/15/2023	Mercer Global Advisors Inc. ADV	14,259	$0.11M	0.0%	N/A	0.007%
11/15/2023	The Manufacturers Life Insurance Company	74,727	$0.57M	0.0%	+31.7%	0.035%
11/15/2023	Laurion Capital Management LP	907,616	$6.94M	0.0%	-71.4%	0.421%
11/15/2023	Legal & General Group Plc	118,050	$0.90M	0.0%	+5.8%	0.055%
11/15/2023	Alps Advisors Inc.	156,214	$1.20M	0.0%	+10.5%	0.072%
11/15/2023	AXQ Capital LP	29,000	$0.22M	0.1%	N/A	0.013%
11/14/2023	Lazard Asset Management LLC	335,024	$2.56M	0.0%	-2.9%	0.155%
11/14/2023	California State Teachers Retirement System	144,330	$1.10M	0.0%	-8.9%	0.067%
11/14/2023	Tower Research Capital LLC TRC	8,290	$63K	0.0%	-55.2%	0.004%

Data available starting January 2016

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $7.57

$7.51

$7.77

50 Day Range

MA: $10.91

$7.79

$15.52

52 Week Range

Now: $7.57

$4.54

$16.75

Volume

3,826,042 shs

Average Volume

6,711,306 shs

Market Capitalization

$1.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

Who are the company insiders with the largest holdings of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top insider investors include:
Mubadala Investment Co Pjsc (Major Shareholder)
Blake Borgeson (Director)
Michael Secora (CFO)
Christopher Gibson (CEO)
Tina Marriott (COO)
Tina Marriott Larson (COO)
Dean Y Li (Director)
Shafique Virani (Insider)
Terry-Ann Burrell (Director)
Zavain Dar (Director)
Learn More about top insider investors at Recursion Pharmaceuticals.
Who are the major institutional investors of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top institutional investors include:
Green Alpha Advisors LLC — 0.03%
TB Alternative Assets Ltd. — 0.03%
Wedmont Private Capital — 0.01%
Learn More about top institutional investors of Recursion Pharmaceuticals stock.
Which institutional investors are buying Recursion Pharmaceuticals stock?: During the previous quarter, RXRX stock was purchased by institutional investors including:
TB Alternative Assets Ltd.
Green Alpha Advisors LLC
Wedmont Private Capital